Navigation Links
New Breakthrough Treatment For Evaporative Dry Eye Disease Introduced By Dry Eye Specialist, Mark R. Mandel, M.D.
Date:12/11/2012

HAYWARD, Calif., Dec. 11, 2012 /PRNewswire/ -- Mark R. Mandel, M.D. , subspecialist in external eye conditions and dry eye, in practice in the Bay Area for 30 years, today announced that he is the first in the Northern California area to introduce a new treatment for the hundreds of thousands of patients in Northern California who suffer from Evaporative Dry Eye disease. This common condition stems from a deficiency in the oily lipid layer of the eye's natural tear film. The oily lipids serve as a protective layer so that the aqueous (water) layer of the eye's tear film does not evaporate. Dr. Mandel has introduced the recently FDA approved, advanced, in-office treatment, called LipiFlow®, which is intended to treat patients with blocked eyelid oil glands, called meibomian gland dysfunction, by unblocking the glands and allowing them to resume the secretion of oily lipids critical for a healthy tear film. Prior to this new treatment, there has been no effective treatment for this pervasive, troublesome, and often debilitating condition.

Dry eye disease affects more than 100 million people worldwide. Of those, 65 percent suffer from Evaporative Dry Eye. Common symptoms of dry eye include dryness, grittiness, soreness, irritation, burning, watering, and eye fatigue. These symptoms can significantly hinder people's daily activities such as reading, using the computer, wearing contact lenses and being outdoors on windy days, or in an air conditioned environment. Many dry eye patients complain that those symptoms worsen throughout the day. "The symptoms of dry eye disease are one of the most common reasons people visit the eye doctor," said Dr. Mandel. "As dry eye specialists, we are thrilled to be able to offer the new LipiFlow treatment to help those patients who are frustrated with this chronic condition and all of the ways it negatively impacts their lives. Most patients note significant symptom relief."

About Mark Mandel, M.D. and Optima Ophthalmic Medical Associates, Inc.

Dr. Mandel was born and raised in Los Angeles. He graduated with Honors from Oxford University, England, receiving both a Bachelors and Masters Degree. He received his Medical Degree from UCLA School of Medicine and completed his ophthalmology residency at Pacific Presbyterian Hospital in San Francisco. Following this, he took an additional year to subspecialize in corneal transplant surgery and conditions of the external eye such as dry eye and meibomian gland dysfunction (MGD) at the University of Iowa, one of the most prestigious cornea and external eye disease programs in the world.

Dr. Mandel teaches and lectures throughout the U.S. and abroad to eye physicians on different aspects of cataract, corneal, and refractive surgery as well as dry eye and meibomian gland dysfunction. He also teaches at the University of California, Berkeley, UCSF, and at the California Pacific Medical Center in San Francisco.

Dr. Mandel has been selected by hundreds of eye doctors and other physicians to perform LASIK, corneal transplant, cataract surgery, and LipiFlow treatment on themselves, their families, and their office staff, who trust him for his knowledge and surgical skill, and rely on him for his experience, honesty and integrity.

His offices are in Hayward, San Leandro, Concord, and Santa Clara. For more information, visit www.optimaeye.com.

http://youtu.be/obZh0dfMf30


'/>"/>
SOURCE Optima Ophthalmic Medical Associates, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Holiday Breakthroughs -- Revolutionizing the Treatment of Cellulite
2. Breakthrough Drug Detection Kit Now Available At The Largest Internet Consumer Site
3. Breakthrough Drug Detection Kit Now Available at the Largest Drug Store Chain in USA
4. Elekta and Philips Establish Research Consortium to Leverage a Breakthrough in Cancer Care with Integration of a Linear Accelerator and MR Imaging
5. DiFUSION Technologies Announces Breakthrough Medical Polymer
6. Latest Breakthroughs and Treatments in Spinal Cord Injury Medicine Bring Top Clinicians and Researchers Together in Las Vegas
7. Major Breakthrough in Hepatitis C Vaccine Development
8. Sony Announces Worlds First Medical-Grade Monitor Utilizing Breakthrough OLED Technology
9. Breakthrough Prostate Cancer Diagnostics
10. Denton Vacuum Ships Breakthrough Wafer-level Optics Development System to Leading German R&D Organization
11. Global Pharmaceutical Leaders All Converging in Parsippany, New Jersey on September 11-12, 2012 for Breakthrough Event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... 2016  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... that the U.S. Food and Drug Administration (FDA) ... application for SB-318, a single treatment strategy intended ... I (MPS I). The SB-318 IND application is ... Phase 1/2 clinical study (SB-318-1502) designed to assess ...
(Date:2/8/2016)... BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA:CTIC) today announced ... Food and Drug Administration (FDA) on February 4, 2016, ... on the clinical studies being conducted under the Company,s ... hold impacts part of the clinical work currently being ... clinical trials. --> ...
(Date:2/5/2016)... Feb. 5, 2016 Amgen (NASDAQ: AMGN ) ... Global Healthcare Conference at 9:15 a.m. ET on Wednesday, Feb. ... David W. Meline , executive vice president and chief ... audio of the presentation can be accessed from the Events ... replay of the webcast will also be available on Amgen,s ...
Breaking Medicine Technology:
(Date:2/8/2016)... , ... February 08, 2016 , ... ... its newly redesigned website, federallabs.org . The site houses a wealth of ... available federal technologies through the process called technology transfer (T2). As a network ...
(Date:2/8/2016)... ... ... famous for gift giving with flowers, chocolates and other tokens of affection meant to remind ... than 5.6 million Americans suffering with Alzheimer’s, those store bought gifts - no matter ... they’ve led and the people they’ve touched. , That’s why Give To ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... and clothing, announced expansion into Canada to provide its range of unique and ... sales office in Quebec City that will provide bilingual customer service and marketing ...
(Date:2/8/2016)... , ... February 08, 2016 , ... Delta Dental of ... help combat pancreatic cancer. , Gary D. Radine, who recently retired as president and ... American Cancer Society’s 2015 CEO of the Year , helped lead the effort ...
(Date:2/8/2016)... ... 08, 2016 , ... FileHold's document management software has been ... cloud hosted environment for FileHold software that is pay per user subscription-based and ... using the FileHold web services API. DocuSyst also advises clients on fully functioning ...
Breaking Medicine News(10 mins):